{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:06:19Z","timestamp":1791414379388,"version":"4.3.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000721, 82170784, 82370775"],"award-info":[{"award-number":["82000721, 82170784, 82370775"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key Research Projects of the Ministry of Science and Technology","award":["2022YFC3602905"],"award-info":[{"award-number":["2022YFC3602905"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08055-8","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:36:20Z","timestamp":1775046980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oxidative stress reprograms benign prostatic hyperplasia microenvironments: insights from integrative multi-omics and machine learning"],"prefix":"10.1186","volume":"24","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangren","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7310-8299","authenticated-orcid":false,"given":"Dehong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"8055_CR1","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.juro.2008.03.141","volume":"179","author":"JT Wei","year":"2008","unstructured":"Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in america project: benign prostatic hyperplasia. J Urol. 2008;179:S75\u201380.","journal-title":"J Urol"},{"key":"8055_CR2","doi-asserted-by":"publisher","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","volume":"3","author":"The global","year":"2022","unstructured":"The global. regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Healthy Longev. 2022;3:e754\u201376.","journal-title":"Lancet Healthy Longev"},{"key":"8055_CR3","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","volume":"54","author":"JC Nickel","year":"2008","unstructured":"Nickel JC, Roehrborn CG, O\u2019Leary MP, Bostwick DG, Somerville MC, Rittmaster RS. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol. 2008;54:1379\u201384.","journal-title":"Eur Urol"},{"key":"8055_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pros.20080","volume":"61","author":"RO Roberts","year":"2004","unstructured":"Roberts RO, Jacobson DJ, Rhodes T, Klee GG, Leiber MM, Jacobsen SJ. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate. 2004;61:124\u201331.","journal-title":"Prostate"},{"key":"8055_CR5","doi-asserted-by":"crossref","unstructured":"Zarakowska E, Guz J, Gackowski D, Olinski R. Relationship between prostate cancer and benign hyperplasia: role of inflammation-induced oxidative stress, vitamin C, and epigenetics. World J Mens Health 2025.","DOI":"10.5534\/wjmh.250116"},{"key":"8055_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0022-5347(17)32831-8","volume":"152","author":"MG Sanda","year":"1994","unstructured":"Sanda MG, Beaty TH, Stutzman RE, Childs B, Walsh PC. Genetic susceptibility of benign prostatic hyperplasia. J Urol. 1994;152:115\u20139.","journal-title":"J Urol"},{"key":"8055_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000366210","volume":"94","author":"PL Minciullo","year":"2015","unstructured":"Minciullo PL, Inferrera A, Navarra M, Calapai G, Magno C, Gangemi S. Oxidative stress in benign prostatic hyperplasia: a systematic review. Urol Int. 2015;94:249\u201354.","journal-title":"Urol Int"},{"key":"8055_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/pros.23100","volume":"76","author":"P Vital","year":"2016","unstructured":"Vital P, Castro P, Ittmann M. Oxidative stress promotes benign prostatic hyperplasia. Prostate. 2016;76:58\u201367.","journal-title":"Prostate"},{"key":"8055_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett. 2009;282:125\u201336.","journal-title":"Cancer Lett"},{"key":"8055_CR10","first-page":"59","volume":"43","author":"AR Hamid","year":"2011","unstructured":"Hamid AR, Umbas R, Mochtar CA. Recent role of inflammation in prostate diseases: chemoprevention development opportunity. Acta Med Indones. 2011;43:59\u201365.","journal-title":"Acta Med Indones"},{"key":"8055_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13510002.2021.1871814","volume":"26","author":"N Jahan","year":"2021","unstructured":"Jahan N, Chowdhury A, Li T, Xu K, Wei F, Wang S. Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway. Redox Rep. 2021;26:1\u20139.","journal-title":"Redox Rep"},{"key":"8055_CR12","doi-asserted-by":"publisher","first-page":"112449","DOI":"10.1016\/j.intimp.2024.112449","volume":"137","author":"C Du","year":"2024","unstructured":"Du C, Wang C, Liu Z, Xin W, Zhang Q, Ali A, Zeng X, Li Z, Ma C. Machine learning algorithms integrate bulk and single-cell RNA data to unveil oxidative stress following intracerebral hemorrhage. Int Immunopharmacol. 2024;137:112449.","journal-title":"Int Immunopharmacol"},{"key":"8055_CR13","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28:882\u20133.","journal-title":"Bioinformatics"},{"key":"8055_CR14","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"8055_CR15","doi-asserted-by":"publisher","first-page":"e2304274","DOI":"10.1002\/advs.202304274","volume":"11","author":"D Lin","year":"2024","unstructured":"Lin D, Luo C, Wei P, Zhang A, Zhang M, Wu X, Deng B, Li Z, Cui K, Chen Z. YAP1 Recognizes Inflammatory and Mechanical Cues to Exacerbate Benign Prostatic Hyperplasia via Promoting Cell Survival and Fibrosis. Adv Sci (Weinh). 2024;11:e2304274.","journal-title":"Adv Sci (Weinh)"},{"key":"8055_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13046-016-0418-8","volume":"35","author":"UK Udensi","year":"2016","unstructured":"Udensi UK, Tchounwou PB. Oxidative stress in prostate hyperplasia and carcinogenesis. J Exp Clin Cancer Res. 2016;35:139.","journal-title":"J Exp Clin Cancer Res"},{"key":"8055_CR17","doi-asserted-by":"crossref","unstructured":"Kaltsas A, Giannakas T, Stavropoulos M, Kratiras Z, Chrisofos M. Oxidative stress in benign prostatic hyperplasia: mechanisms, clinical relevance and therapeutic perspectives. Diseases 2025:13.","DOI":"10.3390\/diseases13020053"},{"issue":"6","key":"8055_CR18","first-page":"e70129","volume":"2025","author":"H Liu","year":"2020","unstructured":"Liu H, Zhou Y, Wang Z, Liu D, Li Y, Lai H, Qiu J, Shan S, Guo F, Chen P, et al, et al. Heat Shock Protein Family A Member 1A Attenuates Apoptosis and Oxidative Stress via ERK\/JNK Pathway in Hyperplastic Prostate. MedComm. 2020;2025(6):e70129.","journal-title":"MedComm"},{"key":"8055_CR19","doi-asserted-by":"crossref","unstructured":"Middleton LW, Shen Z, Varma S, Pollack AS, Gong X, Zhu S, Zhu C, Foley JW, Vennam S, Sweeney RT, et al. Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesis. JCI Insight 2019:5.","DOI":"10.1172\/jci.insight.129749"},{"key":"8055_CR20","doi-asserted-by":"publisher","first-page":"12427","DOI":"10.1038\/s41598-023-39511-w","volume":"13","author":"A Sreekumar","year":"2023","unstructured":"Sreekumar A, Simmons MN, Lee TJ, Sharma A, Saini S. Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model. Sci Rep. 2023;13:12427.","journal-title":"Sci Rep"},{"key":"8055_CR21","doi-asserted-by":"crossref","unstructured":"Liu D, Li M, Fu X, Yang S, Wang Z, Liu J, Li Y, Zhou Y, Ren P, Guo Y, et al. Changes in the expression and functional activities of C-X-C motif chemokine ligand 13 (CXCL13) in hyperplastic prostate. Int J Mol Sci 2022:24.","DOI":"10.3390\/ijms24010056"},{"key":"8055_CR22","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1042\/CS20210476","volume":"135","author":"J Liu","year":"2021","unstructured":"Liu J, Liu D, Zhang X, Li Y, Fu X, He W, Li M, Chen P, Zeng G, DiSanto ME, et al. NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia. Clin Sci (Lond). 2021;135:1591\u2013608.","journal-title":"Clin Sci (Lond)"},{"key":"8055_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jhep.2016.11.005","volume":"66","author":"MJ Monte","year":"2017","unstructured":"Monte MJ, Alonso-Pe\u00f1a M, Briz O, Herraez E, Berasain C, Argemi J, Prieto J, Marin JJG. ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia. J Hepatol. 2017;66:581\u20138.","journal-title":"J Hepatol"},{"key":"8055_CR24","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.7150\/jca.93832","volume":"15","author":"Z Tan","year":"2024","unstructured":"Tan Z, Deng Y, Cai Z, He H, Tang Z, Feng Y, Ye J, Liu R, Cai S, Huang H, et al. ACOX2 Serves as a Favorable Indicator Related to Lipid Metabolism and Oxidative Stress for Biochemical Recurrence in Prostate Cancer. J Cancer. 2024;15:3010\u201323.","journal-title":"J Cancer"},{"key":"8055_CR25","doi-asserted-by":"publisher","first-page":"123192","DOI":"10.1016\/j.lfs.2024.123192","volume":"358","author":"X Fu","year":"2024","unstructured":"Fu X, Wang Y, Lu Y, Liu J, Li H. Association between metabolic syndrome and benign prostatic hyperplasia: The underlying molecular connection. Life Sci. 2024;358:123192.","journal-title":"Life Sci"},{"key":"8055_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12728","volume":"115","author":"M Gacci","year":"2015","unstructured":"Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, Tubaro A, Oelke M, Carini M, Maggi M. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int. 2015;115:24\u201331.","journal-title":"BJU Int"},{"key":"8055_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrurol.2015.301","volume":"13","author":"L Vignozzi","year":"2016","unstructured":"Vignozzi L, Gacci M, Maggi M. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol. 2016;13:108\u201319.","journal-title":"Nat Rev Urol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08055-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:26:47Z","timestamp":1778628407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08055-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8055"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08055-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require further ethics committee approval as it is a retrospective study based on a public database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study is a multi-omics study based on a public database and does not involve the privacy of patients, so it was conducted without informed written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"The authors have no conflicts of interest related to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"670"}}